Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-39
SponsorDana-Farber Cancer Institute
About this trial
This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain significance (VUS).
The name of the intervention used in this research study is:
Nest portal (electronic platform for patients and clinicians)
Eligibility criteria
Qualifiers
Ages 18-39 years, inclusive.
Has had previous cancer genetic testing, with a finding of a pathogenic variant or VUS; patient has previously received results from the clinical team.
English-speaking and -reading.
Receiving care at DFCI.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Nest Platform
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Dana-Farber Cancer Institute
Lead sponsor
Nest Genomics
Collaborator
Source ClinicalTrials.gov